Search research articles
Contact Us
Filters
Showing results (81-90 of 139) with videos related to
Page
of 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2019
Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study
W Victoria Lai, Louisiane Lebas, Tristan A Barnes, et al.
Nature Medicine
|
July 18, 2017
An approach to suppress the evolution of resistance in BRAF<sup>V600E</sup>-mutant cancer
Yaohua Xue, Luciano Martelotto, Timour Baslan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2023
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated <i>KRAS</i> G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
Future Oncology (London, England)
|
November 27, 2023
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
The New England Journal of Medicine
|
June 7, 2021
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
Ferdinandos Skoulidis, Bob T Li, Grace K Dy, et al.
Cancer
|
August 19, 2020
Clinical implications of drug-induced liver injury in early-phase oncology clinical trials
Sebastian P Mondaca, Dazhi Liu, Jessica R Flynn, et al.
Investigational New Drugs
|
March 11, 2017
A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel
Lillian M Smyth, Kelsey R Monson, Komal Jhaveri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 22, 2019
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas
Natasha Rekhtman, Joseph Montecalvo, Jason C Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 11, 2020
<i>MET</i> Exon 14-altered Lung Cancers and MET Inhibitor Resistance
Robin Guo, Michael Offin, A Rose Brannon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2022
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
Nicolas A Giraldo, Esther Drill, Baby A Satravada, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 139) with videos related to
Sort By:
Page
of 14
European Journal of Cancer (Oxford, England : 1990)
|
January 28, 2019
Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study
W Victoria Lai, Louisiane Lebas, Tristan A Barnes, et al.
Nature Medicine
|
July 18, 2017
An approach to suppress the evolution of resistance in BRAF<sup>V600E</sup>-mutant cancer
Yaohua Xue, Luciano Martelotto, Timour Baslan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2023
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated <i>KRAS</i> G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
Future Oncology (London, England)
|
November 27, 2023
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
The New England Journal of Medicine
|
June 7, 2021
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
Ferdinandos Skoulidis, Bob T Li, Grace K Dy, et al.
Cancer
|
August 19, 2020
Clinical implications of drug-induced liver injury in early-phase oncology clinical trials
Sebastian P Mondaca, Dazhi Liu, Jessica R Flynn, et al.
Investigational New Drugs
|
March 11, 2017
A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel
Lillian M Smyth, Kelsey R Monson, Komal Jhaveri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 22, 2019
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas
Natasha Rekhtman, Joseph Montecalvo, Jason C Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 11, 2020
<i>MET</i> Exon 14-altered Lung Cancers and MET Inhibitor Resistance
Robin Guo, Michael Offin, A Rose Brannon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2022
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for Intervention
Nicolas A Giraldo, Esther Drill, Baby A Satravada, et al.
Page
of 14